Vorasidenib Maintenance for IDH Mutant Astrocytoma

Clinical trial NCT06809322 · RECRUITING

Trial details

NCT number: NCT06809322
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

IDH-mutant Grade 2 or 3 Astrocytoma

Start date: 2026-01-16
Primary completion: 2035-04-13
Enrollment: 468

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.